BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16807657)

  • 1. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation.
    Brennan SO; Mosesson MW; Lowen R; Frantz C
    Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
    Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
    Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
    Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
    Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene.
    Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N
    Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
    Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
    Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain].
    Devignes J; Hanss M; Chabaud A; Toussaint-Hacquard M; Mansuy L; De Mazancourt P; Lecompte T
    Ann Biol Clin (Paris); 2013; 71(4):489-95. PubMed ID: 23906582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
    Brennan SO; Laurie A; Smith M
    Thromb Haemost; 2015 Apr; 113(4):903-5. PubMed ID: 25588350
    [No Abstract]   [Full Text] [Related]  

  • 10. Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
    Marchi R; Meyer M; de Bosch N; Soria J; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):285-93. PubMed ID: 15166913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
    Castaman G; Giacomelli SH; Duga S; Rodeghiero F
    Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.
    Homer VM; Brennan SO; Ockelford P; George PM
    Thromb Haemost; 2002 Sep; 88(3):427-31. PubMed ID: 12353071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel homozygous fibrinogen Aα chain truncation causes severe afibrinogenemia with life threatening complications in a two-year-old boy.
    Stikarová J; Blatný J; Kotlín R; Suttnar J; Zapletal O; Pimková K; Májek P; Hrachovinová I; Dyr JE
    Thromb Res; 2013 Oct; 132(4):490-2. PubMed ID: 24050829
    [No Abstract]   [Full Text] [Related]  

  • 15. A nonsense mutation in FGA g.3807C-->T (p.R159X) causes afibrinogenaemia in the homozygous form.
    Marchi Cappelletti R; Tersek Y; Ruiz-Sáez A; Meyer M
    Acta Haematol; 2009; 121(4):216-7. PubMed ID: 19468208
    [No Abstract]   [Full Text] [Related]  

  • 16. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency.
    Zawilska K; Undas A; Fish RJ; Molendowicz-Portala L; De Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2010 Mar; 103(3):677-9. PubMed ID: 20135062
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
    Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
    Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B
    Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze).
    Undas A; Pastuszczak M; Iwaniec T; Kapelak K; Neerman-Arbez M
    Thromb Haemost; 2010 Aug; 104(2):415-7. PubMed ID: 20508898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.